Biotechnology Value Fund L P

13F Holdings History for 4D Molecular Therapeutics, Inc. - Common Stock, par value $0.0001 per share (FDMT)

Symbol: FDMT on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Ownership: 4.63M shares
Security Ownership: 9.99%

BVF PARTNERS L P/IL ownership in 4D Molecular Therapeutics, Inc. Common Stock, par value $0.0001 per share (FDMT)

2025-05-15 - BVF PARTNERS L P/IL has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4.63M shares of 4D Molecular Therapeutics, Inc. Common Stock, par value $0.0001 per share (FDMT). This represents 9.99% percent ownership of the company. In their previous filing dated 2025-02-14, BIOTECHNOLOGY VALUE FUND L P had reported owning 4.83M shares, indicating a decrease of -4.17% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
BVF PARTNERS L P/IL	9.99%		$12.3M	4.63M	-201,548	-4.17%	$2.65	13G/A	3/31/2025	15 May 2025 16:29:12
BVF PARTNERS L P/IL	9.99%		$12.8M	4.83M			$2.65	13G/A	12/31/2024	14 Feb 2025 16:20:18